Cat. No.: DMM-001252
Status | Age | Sex |
---|---|---|
|
|
|
Model Overview | |
---|---|
Model Description | This transgenic mouse model recapitulates human congenital generalized lipodystrophy (CGL) through adipose tissue-specific overexpression of SREBP-1c, which leads to the core characteristics of CGL: a near absence of adipose tissue, severe insulin resistance, and consequent type II diabetes and fatty liver. |
Strain Name | B6;SJL-Tg(aP2-SREBF1c)9884Reh/J |
Background Strain | (C57BL/6J x SJL)F2 |
SPF | Yes |
Research Application | Diabetes |
Target Information | |
---|---|
Target Name | transgene insertion 9884 |
Synonyms | aP2-SREBP-1c436 |
Gene ID | - |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.